These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 22622825
1. Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease. Du XX, Xu HM, Jiang H, Song N, Wang J, Xie JX. Neurosci Bull; 2012 Jun; 28(3):253-8. PubMed ID: 22622825 [Abstract] [Full Text] [Related]
2. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors. El Nebrisi E, Javed H, Ojha SK, Oz M, Shehab S. Int J Mol Sci; 2020 Oct 03; 21(19):. PubMed ID: 33023066 [Abstract] [Full Text] [Related]
4. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease. Liu H, Jia L, Chen X, Shi L, Xie J. Brain Res Bull; 2018 Mar 03; 137():132-139. PubMed ID: 29174294 [Abstract] [Full Text] [Related]
5. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes. Bigham M, Mohammadipour A, Hosseini M, Malvandi AM, Ebrahimzadeh-Bideskan A. Metab Brain Dis; 2021 Jun 03; 36(5):927-937. PubMed ID: 33656625 [Abstract] [Full Text] [Related]
6. Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Sleeman IJ, Boshoff EL, Duty S. Neuropharmacology; 2012 Dec 03; 63(7):1268-77. PubMed ID: 22971544 [Abstract] [Full Text] [Related]
7. Neurorescue effect of rosmarinic acid on 6-hydroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson's disease. Wang J, Xu H, Jiang H, Du X, Sun P, Xie J. J Mol Neurosci; 2012 May 03; 47(1):113-9. PubMed ID: 22205146 [Abstract] [Full Text] [Related]
8. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Xue YQ, Zhao LR, Guo WP, Duan WM. Neuroscience; 2007 May 25; 146(3):1245-58. PubMed ID: 17363174 [Abstract] [Full Text] [Related]
9. The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model. Jamali-Raeufy N, Mojarrab Z, Baluchnejadmojarad T, Roghani M, Fahanik-Babaei J, Goudarzi M. Metab Brain Dis; 2020 Mar 25; 35(3):539-548. PubMed ID: 32016817 [Abstract] [Full Text] [Related]
11. JWH133 attenuates behavior deficits and iron accumulation in 6-OHDA-induced Parkinson's disease model rats. Liu M, Pan D, Wang M, Deng H, Ma Z. J Neurophysiol; 2024 Sep 01; 132(3):733-743. PubMed ID: 39015077 [Abstract] [Full Text] [Related]
16. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats. Lee EY, Lee JE, Park JH, Shin IC, Koh HC. Toxicol Lett; 2012 Sep 18; 213(3):332-44. PubMed ID: 22842585 [Abstract] [Full Text] [Related]
17. Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease. Thornton E, Vink R. PLoS One; 2012 Sep 18; 7(4):e34138. PubMed ID: 22485158 [Abstract] [Full Text] [Related]
18. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease]. Zheng L, Wang H, Ba YY, Liu HL, Wang M, Guo WW, Wu X, Yang H. Zhongguo Zhong Yao Za Zhi; 2014 May 18; 39(9):1660-5. PubMed ID: 25095380 [Abstract] [Full Text] [Related]